The introduction of tyrosine kinase inhibition Imatinib in the treatment of CML has revolutionized the history of the disease making obsolete all the previous therapies; however, in selected cases, old drugs retain their value.
The role of alpha-interferon in chronic myelogenous leukaemia in imatinib era.
FRANCESCHINI, ROBERTO;GARUTI, ANNA;GOBBI, MARCO
2004-01-01
Abstract
The introduction of tyrosine kinase inhibition Imatinib in the treatment of CML has revolutionized the history of the disease making obsolete all the previous therapies; however, in selected cases, old drugs retain their value.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
